Abstract | UNLABELLED: We reported previously that serum parathyroid hormone [ PTH(1-84)]/intact PTH[ PTH(1-84) + PTH(7-84)] ratio provides the better marker for parathyroid function and bone turnover state than serum PTH level itself. The present study demonstrated that higher PTH(1-84)/intact PTH ratio, but not serum PTH(1-84) and intact PTH, predicted higher all-cause mortality in 177 male hemodialysis patients. INTRODUCTION: We reported that PTH(1-84)/intact PTH ratio provides a clinically relevant marker for parathyroid function and the resultant bone turnover state. The purpose of our study was to investigate the association of PTH(1-84)/intact PTH ratio with all-cause mortality (ACM) in male hemodialysis patients. METHODS: The study was performed for 70 months. Serum PTH in 177 male hemodialysis patients was measured with PTH(1-84)-specific whole PTH assay and intact PTH assay which cross-reacts with N-truncated PTH including PTH(7-84). RESULTS: The patients (n = 177) were divided into higher and lower halves based on serum levels of PTH(1-84)/intact PTH ratio (cutoff value, 0.484), intact PTH (143.8 pg/mL), and PTH(1-84) (64.1 pg/mL). In Kaplan-Meier analysis, the higher group in whole PTH/intact PTH ratio had significantly higher ACM than the lower group (P = 0.020 by log-rank test), in contrast with the insignificant difference between the higher and lower groups in intact PTH and PTH(1-84). Multivariate Cox regression hazard analysis identified higher log [ PTH(1-84)/intact PTH ratio], but not log intact PTH or log PTH(1-84) as a significant independent predictor [hazard ratio 14.428 (95% CI 2.486-83.728)] for ACM after adjustment for various factors including age, hemodialysis duration, presence/absence of diabetes mellitus, BMI, log C-reactive protein, serum albumin, calcium, and phosphate. The association existed between log [ PTH(1-84)/intact PTH ratio] and ACM in those without vitamin D administration (n = 95). CONCLUSION: Higher PTH(1-84)/intact PTH ratio, which provides a relevant marker for parathyroid function, may be a significant predictor of ACM in male hemodialysis patients.
|
Authors | M Inaba, S Okuno, Y Imanishi, E Ishimura, T Yamakawa, S Shoji |
Journal | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
(Osteoporos Int)
Vol. 24
Issue 11
Pg. 2863-70
(Nov 2013)
ISSN: 1433-2965 [Electronic] England |
PMID | 24030285
(Publication Type: Journal Article, Observational Study)
|
Chemical References |
- Biomarkers
- Parathyroid Hormone
- Peptide Fragments
- Cholecalciferol
|
Topics |
- Aged
- Biomarkers
(blood)
- Cholecalciferol
(therapeutic use)
- Humans
- Japan
(epidemiology)
- Kaplan-Meier Estimate
- Kidney Failure, Chronic
(diagnosis, mortality, therapy)
- Male
- Middle Aged
- Parathyroid Hormone
(blood)
- Peptide Fragments
(blood)
- Prognosis
- Proportional Hazards Models
- Prospective Studies
- Renal Dialysis
(mortality)
|